Literature DB >> 10364373

Frequency and stability of chromosomal integration of adenovirus vectors.

A Harui1, S Suzuki, S Kochanek, K Mitani.   

Abstract

One of the limitations of adenovirus vectors is the lack of machinery necessary for their integration into host chromosomes, resulting in short-term gene expression in dividing cells. We analyzed frequencies of integration and persistence of gene expression from integrated adenovirus vectors. Both E1-substituted and helper-dependent adenovirus vectors achieved similar integration efficiencies of approximately 10(-3) to 10(-5) per cell, with the helper-dependent vector showing slightly higher efficiencies. In stable cell pools, gene expression of the integrated vector persisted for at least 50 cell divisions without selection. However, some stable cell clones showed changes in gene expression, which were accompanied by structural changes in the integrated vector DNA.

Mesh:

Substances:

Year:  1999        PMID: 10364373      PMCID: PMC112682     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

Authors:  S Kochanek; P R Clemens; K Mitani; H H Chen; S Chan; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

Authors:  Y Yang; S E Haecker; Q Su; J M Wilson
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

3.  In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.

Authors:  S E Haecker; H H Stedman; R J Balice-Gordon; D B Smith; J P Greelish; M A Mitchell; A Wells; H L Sweeney; J M Wilson
Journal:  Hum Gene Ther       Date:  1996-10-01       Impact factor: 5.695

4.  Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.

Authors:  K Overturf; M al-Dhalimy; C N Ou; M Finegold; R Tanguay; A Lieber; M Kay; M Grompe
Journal:  Hum Gene Ther       Date:  1997-03-20       Impact factor: 5.695

5.  Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.

Authors:  R Kumar-Singh; J S Chamberlain
Journal:  Hum Mol Genet       Date:  1996-07       Impact factor: 6.150

6.  Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.

Authors:  K J Fisher; H Choi; J Burda; S J Chen; J M Wilson
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

7.  Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.

Authors:  S Yei; N Mittereder; K Tang; C O'Sullivan; B C Trapnell
Journal:  Gene Ther       Date:  1994-05       Impact factor: 5.250

Review 8.  Transfer of genes to humans: early lessons and obstacles to success.

Authors:  R G Crystal
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

9.  Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors.

Authors:  S K Tripathy; H B Black; E Goldwasser; J M Leiden
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

10.  An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

Authors:  M A Morsy; M Gu; S Motzel; J Zhao; J Lin; Q Su; H Allen; L Franlin; R J Parks; F L Graham; S Kochanek; A J Bett; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  70 in total

1.  Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.

Authors:  M Hillgenberg; H Tönnies; M Strauss
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 4.  Liver-directed gene therapy for dyslipidemia and diabetes.

Authors:  Kazuhiro Oka; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

5.  Induction of fibroblasts to neurons through adenoviral gene delivery.

Authors:  Fengxi Meng; Siye Chen; Qinglong Miao; Kechun Zhou; Qicheng Lao; Xiaohui Zhang; Wenyi Guo; Jianwei Jiao
Journal:  Cell Res       Date:  2011-11-22       Impact factor: 25.617

6.  Expanding horizons of cellular plasticity in regenerative medicine.

Authors:  Chandan K Sen
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

Review 7.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

8.  A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.

Authors:  Hongjie Wang; Dmitry M Shayakhmetov; Tobias Leege; Michael Harkey; Qiliang Li; Thalia Papayannopoulou; George Stamatoyannopolous; André Lieber
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

10.  Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements.

Authors:  Changyu Zheng; Joseph M Vitolo; Weitian Zhang; Fumi Mineshiba; John A Chiorini; Bruce J Baum
Journal:  Mol Ther       Date:  2008-03-25       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.